- Home
- ENX vs RGC Comparison
ENX vs RGC Comparison
Compare ENX & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- RGC
- Stock Information
- Founded
- ENX 2002
- RGC 2014
- Country
- ENX United States
- RGC Hong Kong
- Employees
- ENX N/A
- RGC N/A
- Industry
- ENX Finance/Investors Services
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ENX Finance
- RGC Health Care
- Exchange
- ENX Nasdaq
- RGC Nasdaq
- Market Cap
- ENX 175.5M
- RGC 105.3M
- IPO Year
- ENX N/A
- RGC 2021
- Fundamental
- Price
- ENX $9.48
- RGC $4.86
- Analyst Decision
- ENX
- RGC
- Analyst Count
- ENX 0
- RGC 0
- Target Price
- ENX N/A
- RGC N/A
- AVG Volume (30 Days)
- ENX 25.4K
- RGC 8.8K
- Earning Date
- ENX 01-01-0001
- RGC 10-25-2024
- Dividend Yield
- ENX 3.94%
- RGC N/A
- EPS Growth
- ENX N/A
- RGC N/A
- EPS
- ENX 0.16
- RGC N/A
- Revenue
- ENX N/A
- RGC N/A
- Revenue This Year
- ENX N/A
- RGC N/A
- Revenue Next Year
- ENX N/A
- RGC N/A
- P/E Ratio
- ENX $61.00
- RGC N/A
- Revenue Growth
- ENX N/A
- RGC N/A
- 52 Week Low
- ENX $7.84
- RGC $3.03
- 52 Week High
- ENX $10.07
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- ENX 41.09
- RGC 44.96
- Support Level
- ENX $9.42
- RGC $4.75
- Resistance Level
- ENX $9.89
- RGC $5.21
- Average True Range (ATR)
- ENX 0.12
- RGC 0.30
- MACD
- ENX -0.01
- RGC 0.04
- Stochastic Oscillator
- ENX 29.35
- RGC 23.87
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.